bind < binding < binds

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f Mesh.f MeshFr.f KwdFr.f

List of bibliographic references indexed by binding

Number of relevant bibliographic references: 15.

Ident.	Authors (with country if any)	Title
000052 (2021)	Santanu Santra [Inde] ; Santanab Giri [Inde] ; Madhurima Jana [Inde]	Unraveling the origin of interactions of hydroxychloroquine with the receptor-binding domain of SARS-CoV-2 in aqueous medium.
000330 (2021)	Himanshu Rai [Inde] ; Atanu Barik [Inde] ; Yash Pal Singh [Inde] ; Akhil Suresh [Inde] ; Lovejit Singh [Inde] ; Gourav Singh [Inde] ; Usha Yogendra Nayak [Inde] ; Vikash Kumar Dubey [Inde] ; Gyan Modi [Inde]	Molecular docking, binding mode analysis, molecular dynamics, and prediction of ADMET/toxicity properties of selective potential antiviral agents against SARS-CoV-2 main protease: an effort toward drug repurposing to combat COVID-19.
000355 (2021)	Jacques Fantini [France] ; Henri Chahinian [France] ; Nouara Yahi [France]	Leveraging coronavirus binding to gangliosides for innovative vaccine and therapeutic strategies against COVID-19.
000567 (2021)	Jung-Soo Suh [Corée du Sud] ; Heon-Su Kim [Corée du Sud] ; Tae-Jin Kim [Corée du Sud]	Development of a SARS-CoV-2-derived receptor-binding domain-based ACE2 biosensor.
000706 (2021)	Tanveer A. Wani [Arabie saoudite] ; Ahmed H. Bakheit [Arabie saoudite] ; Abdulrahman A. Al-Majed [Arabie saoudite] ; Nojood Altwaijry [Arabie saoudite] ; Anwar Baquaysh [Arabie saoudite] ; Ashwaq Aljuraisy [Arabie saoudite] ; Seema Zargar [Arabie saoudite]	Binding and drug displacement study of colchicine and bovine serum albumin in presence of azithromycin using multispectroscopic techniques and molecular dynamic simulation.
000914 (2020)	Muhammad Hamza [République populaire de Chine, Pakistan] ; Ashaq Ali [République populaire de Chine] ; Suliman Khan [République populaire de Chine] ; Saeed Ahmed [République populaire de Chine] ; Zarlish Attique [Pakistan] ; Saad Ur Rehman [Pakistan] ; Ayesha Khan [Pakistan] ; Hussain Ali [Pakistan] ; Muhammad Rizwan [Pakistan] ; Anum Munir [Pakistan] ; Arshad Mehmood Khan [Pakistan] ; Faiza Siddique [Pakistan] ; Azhar Mehmood [Pakistan] ; Faisal Nouroz [Pakistan] ; Sajid Khan [Pakistan]	nCOV-19 peptides mass fingerprinting identification, binding, and blocking of inhibitors flavonoids and anthraquinone of Moringa oleifera and hydroxychloroquine.
000983 (2020)	Mohammed H. Shalayel [Arabie saoudite] ; Ghassab M. Al-Mazaideh [Arabie saoudite] ; Saleem H. Aladaileh [Arabie saoudite] ; Farhan K. Al-Swailmi [Arabie saoudite] ; Mohammad G. Al-Thiabat [Malaisie]	Vitamin D is a potential inhibitor of COVID-19: In silico molecular docking to the binding site of SARS-CoV-2 endoribonuclease Nsp15.
000B62 (2020)	Senthilnathan Rajendaran [Inde] ; Arunchalam Jothi [Inde] ; Veerappan Anbazhagan [Inde]	Targeting the glycan of receptor binding domain with jacalin as a novel approach to develop a treatment against COVID-19.
000C27 (2020)	Mallikarjuna Nimgampalle [Inde] ; Vasudharani Devanathan [Inde] ; Ambrish Saxena [Inde]	Screening of Chloroquine, Hydroxychloroquine and its derivatives for their binding affinity to multiple SARS-CoV-2 protein drug targets.
000E26 (2020)	Petar M. Mitrasinovic	Prediction of Single Point Mutations in Human Coronavirus and Their Effects on Binding to 9-O-Acetylated Sialic Acid and Hidroxychloroquine.
000F42 (2020)	Priyanka Sharma [Inde] ; Asifkhan Shanavas [Inde]	Natural derivatives with dual binding potential against SARS-CoV-2 main protease and human ACE2 possess low oral bioavailability: a brief computational analysis.
000F64 (2020)	Hadjer Khelfaoui [Algérie] ; Dalal Harkati [Algérie] ; Basil A. Saleh [Iraq]	Molecular docking, molecular dynamics simulations and reactivity, studies on approved drugs library targeting ACE2 and SARS-CoV-2 binding with ACE2.
001416 (2020)	Muhammad Amin [Pakistan] ; Ghazanfar Abbas [Pakistan]	Docking study of chloroquine and hydroxychloroquine interaction with RNA binding domain of nucleocapsid phospho-protein - an in silico insight into the comparative efficacy of repurposing antiviral drugs.
001526 (2020)	Dhaval Patel [Inde] ; Mohd Athar [Inde] ; P C Jha [Inde]	Computational investigation of binding of chloroquinone and hydroxychloroquinone against PLPro of SARS-CoV-2.
001894 (2020)	Moussa Sehailia [Algérie] ; Smain Chemat [Algérie]	Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hotspots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "binding" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "binding" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    binding
}}

---

This area was generated with Dilib version V0.6.38. Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021